GlassScriptPhysician profile
Eric T Sandberg
NPI 1427144609
$6,077.36
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,151 · 2020: $116 · 2021: $297 · 2022: $1,142 · 2023: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $3,663.53 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $990.46 | 2019-2023 | |
| Genzyme Corporation | $246.99 | 2022-2023 | |
| Grifols USA, LLC | $220.47 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $204.79 | 2022-2023 | |
| Glaxosmithkline, LLC. | $191.47 | 2019 | |
| Adma Biomanufacturing LLC | $170.83 | 2022 | |
| Incyte Corporation | $125.99 | 2022 | |
| Pharming Healthcare, INC. | $102.80 | 2019 | |
| Alk-Abello, INC | $76.56 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $42.45 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sandberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.